What is the HPV 9-valent vaccine? Why is it so hard to get a shot? Be sure to keep your eyes open when making an appointment! (I)

As the first vaccine that can prevent cervical cancer, the nine-valent HPV vaccine can be called an internet celebrity in the vaccine industry. It fell into a shortage dilemma as soon as it came out, and some scalpers even started to provide services to grab the vaccine on behalf of others.

So what is the nine-valent vaccine? Is it necessary to get it? What should we pay attention to? Let's learn about it together!

What is HPV?

When it comes to the nine-valent vaccine, we must first know what HPV is. Human papillomavirus (HPV) is an important factor causing cervical cancer.

Currently, the HPV vaccines available are bivalent, quadrivalent, and nonavalent. The “valent” refers to the number of virus subtypes targeted.

The nine-valent vaccine, that is, HPV, has a wider coverage. It targets nine subtypes of HPV viruses, mainly 6, 11, 16, 18, 31, 33, 45, 52, and 58.

The role of the nine-valent vaccine

The nine-valent vaccine can prevent approximately 93% of cervical cancer and about 90% of genital warts.

Therefore, the nine-valent HPV vaccine is more popular, making it difficult to get a shot.

Precautions for 9-valent vaccine

It should be noted that the vaccination procedure is a total of three injections, one after the first shot, and two after 2 months and 6 months. It is mainly suitable for women aged 16-26.

-Specific content as shown in the picture-

In the next issue, we will talk about the relevant cervical cancer screening precautions and HPV vaccination fraud prevention guidelines, don’t miss it~

Note: There is no copyright issue for the pictures in this article

Author: Shen Xinya Bixia Zhao Jiangxia

About the Author

Bi Xia

Bi Xia, Doctor of Medicine, Chief Physician, Master Supervisor, is currently the Director of the Department of Rehabilitation Medicine, Zhoupu Hospital Affiliated to Shanghai University of Medicine and Medical Sciences, and the Vice President of the School of Rehabilitation, Shanghai University of Medicine and Medical Sciences. In 2010, 2018 and 2019, she was selected into the Excellent Discipline Leader and Leading Talent Training Program of the Health System of Pudong New Area. She has published 4 SCI papers and more than 30 core journal papers as the first author and corresponding author.

Professional fields: stroke rehabilitation, fracture postoperative rehabilitation, spinal cord injury rehabilitation, artificial joint perioperative rehabilitation, hand injury rehabilitation, etc.

Main academic positions: Member of the Geriatric Rehabilitation Branch of the Chinese Rehabilitation Medicine Association, Member of the Medical and Nursing Integration Committee of the Chinese Rehabilitation Medicine Association, Rehabilitation Committee Member of the Geriatric Rehabilitation Branch of the Chinese Medical Doctor Association, Executive Director of the Shanghai Rehabilitation Medicine Association, Member of the Physical Medicine and Rehabilitation Branch of the Shanghai Medical Association, Vice Chairman of the Rehabilitation Treatment Committee of the Shanghai Rehabilitation Medicine Association, Member of the Orthopedic Rehabilitation Committee of the Shanghai Rehabilitation Medicine Association, Member of the Spinal Cord Injury Rehabilitation Committee of the Shanghai Rehabilitation Medicine Association, Member of the Community Rehabilitation Committee of the Shanghai Rehabilitation Medicine Association, Member of the Sports Health and Rehabilitation Committee of the Shanghai Rehabilitation Medicine Association, Chairman of the Rehabilitation and Physiotherapy Committee of the Shanghai Pudong New Area Medical Association, and other academic positions.

Funded by Shanghai Science and Technology Commission's Science Popularization Project

(Project No.: 20DZ2311100)